After the rejection of Lykos Therapeutics’ MDMA-based PTSD treatment tempered excitement for psychedelic therapeutics, a ...

Months after Massachusetts voters rejected a ballot question that would permit adults to use and grow certain psychedelic drugs, some state lawmakers have begun proposing bills to legalize psilocybin.

The largest life sciences association in the state recognized those driving discovery during its 32nd annual dinner meeting ...

Johnson & Johnson's Spravato therapy for treatment-resistant depression (TRD ... provides further evidence for the use of esketamine nasal spray in this difficult-to-treat population and offers ...

The only FDA-approved option is Spravato, a nasal spray made from a derivative of ketamine, which is used for treatment-resistant depression and major depressive disorder in adults. Ketamine is also ...

Ketaly delivers premium ketamine in an hour for fast, safe relief from anxiety, depression, pain, and mental clarity.

Major depressive disorder (MDD) is a leading cause of disability worldwide, with a significant proportion of patients (10-20%) progressing to treatment-resistant depression (TRD).

Ketamine is commonly administered via intravenous infusion, although other routes, such as nasal and oral ... its effectiveness in other forms of depression, such as bipolar disorder, has not ...

Ketamine, a non-competitive N-methyl-D-aspartate receptor antagonist, has emerged as an effective therapeutic agent for the management of treatment-resistant depression. Repeated treatments with ...

Ketamine has come a long way from its reputation as a party drug and veterinary anesthetic. In recent years, it has been used in medical treatments for conditions like depression and post ...